Olaf Riess

About Olaf Riess

Olaf Riess, With an exceptional h-index of 98 and a recent h-index of 55 (since 2020), a distinguished researcher at Eberhard Karls Universität Tübingen, specializes in the field of Humangenetik.

His recent articles reflect a diverse array of research interests and contributions to the field:

RFC1 repeat expansions in downbeat nystagmus syndromes: frequency and phenotypic profile

Community effort to unravel the complex human neuronal landscape exemplified for the striatum

Diagnostic genome sequencing improves diagnostic yield: a prospective single-centre study in 1000 patients with inherited eye diseases

Stage‐dependent biomarker changes in spinocerebellar ataxia type 3

Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy

A further case of AFG2B‐related neurodevelopmental disorder with hearing loss and microcephaly allows further clarification of pathogenicity of the variant c.1313T …

A GGC-repeat expansion in ZFHX3 encoding polyglycine causes spinocerebellar ataxia type 4 and impairs autophagy

Resequencing the complete SNCA locus in Indian patients with Parkinson’s disease

Olaf Riess Information

University

Position

Professor der Humangenetik

Citations(all)

41071

Citations(since 2020)

14359

Cited By

30548

hIndex(all)

98

hIndex(since 2020)

55

i10Index(all)

387

i10Index(since 2020)

249

Email

University Profile Page

Google Scholar

Olaf Riess Skills & Research Interests

Humangenetik

Top articles of Olaf Riess

RFC1 repeat expansions in downbeat nystagmus syndromes: frequency and phenotypic profile

Journal of Neurology

2024/2/21

Olaf Riess
Olaf Riess

H-Index: 50

Diagnostic genome sequencing improves diagnostic yield: a prospective single-centre study in 1000 patients with inherited eye diseases

Journal of Medical Genetics

2024/2/1

Olaf Riess
Olaf Riess

H-Index: 50

Stage‐dependent biomarker changes in spinocerebellar ataxia type 3

Annals of neurology

2024/2

Augmenting MEK inhibitor efficacy in BRAF wild-type melanoma: synergistic effects of disulfiram combination therapy

Journal of Experimental & Clinical Cancer Research

2024/1/23

A further case of AFG2B‐related neurodevelopmental disorder with hearing loss and microcephaly allows further clarification of pathogenicity of the variant c.1313T …

Molecular Genetics & Genomic Medicine

2024/1

Olaf Riess
Olaf Riess

H-Index: 50

A GGC-repeat expansion in ZFHX3 encoding polyglycine causes spinocerebellar ataxia type 4 and impairs autophagy

Nature Genetics

2024/4/29

Resequencing the complete SNCA locus in Indian patients with Parkinson’s disease

npj Parkinson's Disease

2024/4/15

A Novel PINK1 p.F385S Loss‐of‐Function Mutation in an Indian Family with Parkinson's Disease

Movement Disorders

2024/4/8

Genomes in clinical care

2024/3/14

Olaf Riess
Olaf Riess

H-Index: 50

Christopher Schroeder
Christopher Schroeder

H-Index: 5

p62, the Receptor for Selective Autophagy, Contributes in ATXN3 Aggregate Formation in Spinocerebellar Ataxia Type 3

2024/3/7

Blood and cerebellar abundance of ATXN3 splice variants in spinocerebellar ataxia type 3/Machado-Joseph disease

Neurobiology of Disease

2024/2/27

Rebecca Tagett
Rebecca Tagett

H-Index: 12

Olaf Riess
Olaf Riess

H-Index: 50

UV-radiation and MC1R germline mutations are risk factors for the development of conventional and spitzoid melanomas in children and adolescents

EBioMedicine

2023/10/1

Clinical trio genome sequencing facilitates the interpretation of variants in cancer predisposition genes in paediatric tumour patients

European Journal of Human Genetics

2023/10

Blood transcriptome sequencing identifies biomarkers able to track disease stages in spinocerebellar ataxia type 3

Brain

2023/10

Olaf Riess
Olaf Riess

H-Index: 50

Frequency and Phenotype of RFC1 Repeat Expansions in Bilateral Vestibulopathy

Neurology

2023/9/5

TMB and BRAF mutation status are independent predictive factors in high-risk melanoma patients with adjuvant anti-PD-1 therapy

Journal of Cancer Research and Clinical Oncology

2023/2

See List of Professors in Olaf Riess University(Eberhard Karls Universität Tübingen)